These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33923202)

  • 1. Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.
    Keegan DE; Brewington JJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical CFTR expression in human nasal epithelium correlates with lung disease in cystic fibrosis.
    van Meegen MA; Terheggen-Lagro SW; Koymans KJ; van der Ent CK; Beekman JM
    PLoS One; 2013; 8(3):e57617. PubMed ID: 23483918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells.
    Scudieri P; Musante I; Venturini A; Guidone D; Genovese M; Cresta F; Caci E; Palleschi A; Poeta M; Santamaria F; Ciciriello F; Lucidi V; Galietta LJV
    Cells; 2020 Sep; 9(9):. PubMed ID: 32933106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of rescue of F508del-CFTR function by VX-809 and VX-770 in human nasal epithelial cells correlates with SNP rs7512462 in SLC26A9 gene in F508del/F508del Cystic Fibrosis patients.
    Kmit A; Marson FAL; Pereira SV; Vinagre AM; Leite GS; Servidoni MF; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Amaral MD
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1323-1331. PubMed ID: 30716472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pediatric cystic fibrosis airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal cytology brush sampling.
    Schögler A; Blank F; Brügger M; Beyeler S; Tschanz SA; Regamey N; Casaulta C; Geiser T; Alves MP
    Respir Res; 2017 Dec; 18(1):215. PubMed ID: 29282053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
    Andersson C; Dragomir A; Hjelte L; Roomans GM
    Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.
    Joynt AT; Evans TA; Pellicore MJ; Davis-Marcisak EF; Aksit MA; Eastman AC; Patel SU; Paul KC; Osorio DL; Bowling AD; Cotton CU; Raraigh KS; West NE; Merlo CA; Cutting GR; Sharma N
    PLoS Genet; 2020 Oct; 16(10):e1009100. PubMed ID: 33085659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunocytochemical assay to detect human CFTR expression following gene transfer.
    Davidson H; Wilson A; Gray RD; Horsley A; Pringle IA; McLachlan G; Nairn AC; Stearns C; Gibson J; Holder E; Jones L; Doherty A; Coles R; Sumner-Jones SG; Wasowicz M; Manvell M; Griesenbach U; Hyde SC; Gill DR; Davies J; Collie DD; Alton EW; Porteous DJ; Boyd AC
    Mol Cell Probes; 2009 Dec; 23(6):272-80. PubMed ID: 19615439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal potential difference measurements to assess CFTR ion channel activity.
    Rowe SM; Clancy JP; Wilschanski M
    Methods Mol Biol; 2011; 741():69-86. PubMed ID: 21594779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
    Sands D
    Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.
    Vijftigschild LA; Berkers G; Dekkers JF; Zomer-van Ommen DD; Matthes E; Kruisselbrink E; Vonk A; Hensen CE; Heida-Michel S; Geerdink M; Janssens HM; van de Graaf EA; Bronsveld I; de Winter-de Groot KM; Majoor CJ; Heijerman HG; de Jonge HR; Hanrahan JW; van der Ent CK; Beekman JM
    Eur Respir J; 2016 Sep; 48(3):768-79. PubMed ID: 27471203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies.
    Carvalho-Oliveira I; Efthymiadou A; Malhó R; Nogueira P; Tzetis M; Kanavakis E; Amaral MD; Penque D
    J Histochem Cytochem; 2004 Feb; 52(2):193-203. PubMed ID: 14729871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation.
    Black HR; Yankaskas JR; Johnson LG; Noah TL
    Am J Respir Cell Mol Biol; 1998 Aug; 19(2):210-5. PubMed ID: 9698592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of CFTR function and modulation in primary human nasal cell spheroids.
    Brewington JJ; Filbrandt ET; LaRosa FJ; Ostmann AJ; Strecker LM; Szczesniak RD; Clancy JP
    J Cyst Fibros; 2018 Jan; 17(1):26-33. PubMed ID: 28712885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.
    Tipirneni KE; Cho DY; Skinner DF; Zhang S; Mackey C; Lim DJ; Woodworth BA
    Laryngoscope; 2017 Nov; 127(11):E384-E391. PubMed ID: 28771736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators.
    Pranke IM; Hatton A; Simonin J; Jais JP; Le Pimpec-Barthes F; Carsin A; Bonnette P; Fayon M; Stremler-Le Bel N; Grenet D; Thumerel M; Mazenq J; Urbach V; Mesbahi M; Girodon-Boulandet E; Hinzpeter A; Edelman A; Sermet-Gaudelus I
    Sci Rep; 2017 Aug; 7(1):7375. PubMed ID: 28785019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers.
    Pizurki L; Morris MA; Chanson M; Solomon M; Pavirani A; Bouchardy I; Suter S
    Am J Pathol; 2000 Apr; 156(4):1407-16. PubMed ID: 10751364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.